Does REGORAFENIB Cause Mucosal inflammation? 128 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 128 reports of Mucosal inflammation have been filed in association with REGORAFENIB (Stivarga). This represents 1.4% of all adverse event reports for REGORAFENIB.
128
Reports of Mucosal inflammation with REGORAFENIB
1.4%
of all REGORAFENIB reports
33
Deaths
42
Hospitalizations
How Dangerous Is Mucosal inflammation From REGORAFENIB?
Of the 128 reports, 33 (25.8%) resulted in death, 42 (32.8%) required hospitalization, and 3 (2.3%) were considered life-threatening.
Is Mucosal inflammation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REGORAFENIB. However, 128 reports have been filed with the FAERS database.
What Other Side Effects Does REGORAFENIB Cause?
Off label use (1,906)
Fatigue (1,530)
Palmar-plantar erythrodysaesthesia syndrome (1,230)
Diarrhoea (1,221)
Decreased appetite (941)
Asthenia (825)
Death (813)
Dysphonia (702)
Nausea (688)
Pain in extremity (686)
What Other Drugs Cause Mucosal inflammation?
METHOTREXATE (3,352)
CYCLOPHOSPHAMIDE (2,535)
DOXORUBICIN (1,939)
VINCRISTINE (1,594)
ETOPOSIDE (1,591)
FLUOROURACIL (1,481)
RITUXIMAB (1,364)
CYTARABINE (1,337)
CAPECITABINE (1,262)
CARBOPLATIN (1,259)
Which REGORAFENIB Alternatives Have Lower Mucosal inflammation Risk?
REGORAFENIB vs REGORAFENIB\REGORAFENIB
REGORAFENIB vs RELATLIMAB
REGORAFENIB vs RELPAX
REGORAFENIB vs RELUGOLIX
REGORAFENIB vs REMDESIVIR